Merck Czech Republic - Balance Sheet

Assets and their Funding (CZK mil)
Pharmaceutical | Czechia | April 2, 2020
$10.99
Excel Sheet

Merck Czech Republic's total assets reached CZK 774 mil at the end of 2017, up 6.64% compared to the previous year.

Current assets amounted to CZK 604 mil, or 78.1% of total assets while cash stood at CZK 25.1 mil at the end of 2017.

By contrast, total debt reached CZK 0 mil at the year-end, or 0% of total assets, while the firm's equity amounted to CZK 674 mil. As a result, net debt stood at CZK -25.1 mil at the end of 2017 and accounted for -3.73% of equity.

Net debt against equity is down 44.0 pp from five years ago (40.2%). The ratio against EBITDA decreased from 1.39x seen in 2012 to -0.345x.

The company’s cost of funding amounted to in 2017, down 27.1 pp compared to the average over the last 5 years.

You can see all the company’s data at Merck Czech Republic profile, or you can download a report on the company in the report section.